Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study. J of Skin [Internet]. 2024 Nov. 18 [cited 2025 Apr. 26];8(6):s500. Available from: https://skin.dermsquared.com/skin/article/view/3073